Peterson & Co. acts for Revive Therapeutics Ltd. in Rights Offering
On May 16, 2016, Revive Therapeutics Ltd. (TSXV: RVV) announced a best efforts rights offering to raise $2.2 million. Revive is focused on commercializing treatments for gout, and rare diseases such as cystinuria, Wilson’s disease and Rett syndrome.
Peterson McVicar Acts for Red Cloud Securities Inc. in Brokered Private Placement with Grounded Lithium for up to C$5.0 Million
Peterson McVicar Acts for HIVE Blockchain in At-The-Market Equity Program